GlassScriptPhysician profile
Masroor A Abro
NPI 1841528775
$10,331.91
in general payments reported to CMS, 2019-2025
29 companies · $585 in 2025
The $585 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,067 · 2020: $37.45 · 2021: $604 · 2022: $3,723 · 2023: $151 · 2024: $3,166 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,962 · Food and Beverage: $1,939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,961.94 |
| Food and Beverage | $1,939.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,760.58 | 2019-2025 | Watchman Flx, Avvigo Guidance System, Comet |
| Medtronic, INC. | $1,815.42 | 2021-2024 | Micra, Linq II, Azure Xt Dr Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $319.85 | 2019-2025 | Lifevest |
| Amgen INC. | $284.33 | 2019-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $273.65 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $258.80 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $218.34 | 2019-2025 | Wainua, Farxiga, Lokelma |
| Abbott Laboratories | $211.98 | 2021-2025 | Confirm Rx, Cardiomems |
| Amarin Pharma, INC. | $185.30 | 2019 | |
| Novartis Pharmaceuticals Corporation | $175.28 | 2019-2025 | |
| Philips North America LLC | $166.11 | 2023-2025 | (Ck4) Mcot, (Ck7) Extended Holter, Mcot |
| Actelion Pharmaceuticals US, INC. | $92.97 | 2022-2024 | Opsumit, Uptravi |
| Bardy Diagnostics, INC. | $65.00 | 2019-2020 | |
| Novo Nordisk INC | $51.62 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Baxter Healthcare | $50.98 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $47.00 | 2025 | |
| Pfizer INC. | $45.41 | 2019-2025 | |
| Lantheus Medical Imaging, INC. | $41.97 | 2020-2024 | |
| Kestra Medical Technology Services, INC. | $36.86 | 2023-2025 | Assure Wcd |
| Medtronic Vascular, INC. | $36.38 | 2019 | |
| Impulse Dynamics (USA) INC. | $36.36 | 2021 | |
| Portola Pharmaceuticals, LLC | $31.75 | 2019 | |
| Lundbeck LLC | $31.70 | 2019 | |
| Terumo Medical Corporation | $20.19 | 2024 | Angio-Seal, Glidesheath Slender |
| Merck Sharp & Dohme LLC | $17.48 | 2023 | Verquvo |
| Glaxosmithkline, LLC. | $16.88 | 2025 | Arexvy, Shingrix |
| Astellas Pharma US INC | $14.01 | 2019 | |
| Abiomed | $13.99 | 2025 | |
| Gilead Sciences, INC. | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Masroor Abro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.